Antibody–drug conjugates: Recent advances in linker chemistry

Antibody–drug conjugates (ADCs) are gradually revolutionizing clinical cancer therapy. The antibody–drug conjugate linker molecule determines both the efficacy and the adverse effects, and so has a major influence on the fate of ADCs. An ideal linker should be stable in the circulatory system and re...

Full description

Saved in:
Bibliographic Details
Published inActa pharmaceutica Sinica. B Vol. 11; no. 12; pp. 3889 - 3907
Main Authors Su, Zheng, Xiao, Dian, Xie, Fei, Liu, Lianqi, Wang, Yanming, Fan, Shiyong, Zhou, Xinbo, Li, Song
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.12.2021
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…